Cannabis Marijuana, THC Urine Spot

Blood

Report in 48Hrs

At Home

No Fasting Required

Details

Rapid urine test for marijuana use.

₹888₹1,269

30% OFF

Cannabis Marijuana THC Urine Spot Test Information Guide

Why is it done?
- Detects the presence of tetrahydrocannabinol (THC) metabolites in urine, indicating cannabis use within the past several days to weeks
- Workplace drug screening programs and employment pre-screening to identify substance use
- Legal and forensic purposes, including court-ordered testing and probation monitoring
- Sports and athletic competition testing to ensure fair play and compliance with anti-doping policies
- Clinical assessment of substance use disorders and monitoring of individuals in addiction treatment programs
- School and educational institution drug testing programs for student athletes and applicants
- Medical evaluation in emergency departments or for patients presenting with signs of intoxication
Normal Range
- Standard Cutoff Levels: Negative Result: Less than 50 ng/mL (nanograms per milliliter) - most common screening cutoff Positive Result: 50 ng/mL or greater - indicates THC metabolite presence
- Higher Sensitivity Cutoff: Negative: Less than 20 ng/mL Positive: 20 ng/mL or greater
- Units of Measurement: ng/mL (nanograms per milliliter of urine)
- Result Interpretation: Negative: No detectable THC metabolites at or above the specified cutoff; indicates no recent cannabis use or levels below detection threshold Positive: THC metabolites detected above the cutoff level; indicates cannabis use within recent period (typically within 2-30 days depending on frequency of use) Borderline/Weakly Positive: Results near the cutoff that may warrant confirmatory testing
Interpretation
- Negative Result (<50 ng/mL): Indicates no detectable THC metabolites above the laboratory threshold May indicate abstinence from cannabis or use beyond the detection window Does not exclude remote or occasional use
- Positive Result (≥50 ng/mL): Confirms presence of THC metabolites in urine Suggests cannabis use within the preceding 2-30 days Heavy or chronic users may test positive for extended periods (up to 30-60 days) Occasional users typically test positive for 3-4 days after use Does not indicate current impairment or time of use
- Detection Window Variations: Single Use: 2-4 days Regular Use (2-4 times weekly): 5-7 days Heavy/Daily Use: 10-30+ days
- Factors Affecting Results: Frequency of cannabis use (chronic users have prolonged detection) Route of administration (smoking vs. edibles may affect timing) Individual metabolism and body fat percentage Hydration status and urine concentration Sensitivity of the testing method used CBD products that contain trace THC amounts Hemp-derived products with negligible THC content
- Clinical Significance: Positive results indicate recent cannabis exposure but do NOT measure impairment THC metabolites remain in urine long after intoxication effects wear off Cross-reactivity with certain medications or foods is generally minimal with modern immunoassays Confirmatory testing (GC-MS) should follow preliminary positive results in critical settings Results do not indicate legal vs. illegal use or medical vs. recreational use
Associated Organs
- Primary Organ Systems: Central Nervous System (CNS) - primary site of THC action Kidneys - filter and excrete THC metabolites into urine Liver - metabolizes THC into inactive and active compounds Lungs - affected by inhalation route of cannabis
- Medical Conditions Associated with Positive Results: Cannabis Use Disorder (CUD) - chronic excessive use with dependence Substance Use Disorders - polydrug use patterns Cannabis-Induced Psychotic Disorder - in susceptible individuals Cannabinoid Hyperemesis Syndrome (CHS) - chronic nausea from heavy use Cannabis-Related Anxiety Disorders Impaired Driving or Operating Machinery - potential impairment during positive period
- Potential Health Complications Associated with Cannabis Use: Respiratory issues - chronic bronchitis, airway damage (if smoked) Cognitive impairment - memory, attention, and executive function deficits with heavy use Cardiovascular effects - increased heart rate, potential arrhythmias Mental health complications - anxiety, depression, psychosis risk Reproductive concerns - potential effects on male fertility and fetal development Cannabis-related emergency department visits - acute medical events
- Kidney Function Context: THC metabolites are water-soluble and excreted through renal filtration Impaired kidney function may affect metabolite clearance Urine concentration and hydration status influence test sensitivity
Follow-up Tests
- Confirmatory Testing: Gas Chromatography-Mass Spectrometry (GC-MS) - gold standard for confirmation of positive results Liquid Chromatography-Mass Spectrometry (LC-MS) - highly specific confirmatory method Quantitative THC metabolite testing - determines exact concentration levels
- Clinical Assessment Tests (if positive): Comprehensive Metabolic Panel (CMP) - assess liver and kidney function Complete Blood Count (CBC) - screen for general health status Other Drug Screen Testing - assess for concurrent substance use (alcohol, opioids, stimulants) Psychiatric/Behavioral Assessment - evaluate for substance use disorder Pregnancy Testing - for women of childbearing age (THC crosses placenta)
- Impairment Assessment (if positive in safety-sensitive contexts): Saliva/Oral Fluid THC Test - indicates more recent use and impairment window Blood THC Testing - measures active THC levels (better indicator of current impairment) Standardized Field Sobriety Testing (SFST) - for suspected impairment situations Neuropsychological Testing - if cognitive impairment is suspected
- Monitoring for Addiction Treatment: Serial Urine Drug Screens - typically weekly to monthly during treatment programs Behavioral Health Assessment - ongoing evaluation of substance use patterns Liver Function Tests (LFTs) - periodic monitoring for chronic heavy users Mental Health Screening - assess for comorbid psychiatric conditions
- Specialized Follow-up Tests: Urine Validity Testing - pH, creatinine, specific gravity to detect sample tampering Creatinine Level - assess sample dilution (important for interpretation) Specimen Integrity Testing - temperature and color verification
- Monitoring Frequency: Pre-employment: Single test Workplace Safety Programs: Random or reasonable suspicion testing Court-Ordered Monitoring: As specified by court (typically monthly to quarterly) Addiction Treatment: Weekly to monthly during active treatment Probation/Parole: As mandated (frequency varies by jurisdiction and violation history)
Fasting Required?
- Fasting Requirement: No - Fasting is NOT required for this urine test
- Patient Preparation Instructions: No special dietary restrictions Normal eating and drinking can continue Patient may consume food or beverages as usual No fasting period required before test
- Special Considerations: Hydration Status - Patient should provide mid-stream urine; excessive dilution may dilute metabolites but laboratories apply creatinine adjustments Morning Specimen - First morning urine often provides most concentrated specimen with highest THC metabolite levels Timing - Test should be performed as scheduled; no need to alter daily routine
- Medications: No medications need to be discontinued Most medications do not interfere with THC detection Patients should continue their regular medication schedule Notify testing facility of all medications being taken (including OTC and supplements)
- Specimen Collection Instructions: Clean genital area before collection (may use provided wipes) Collect mid-stream urine in provided sterile container Provide at least 30-45 mL of urine (per laboratory requirements) Avoid contamination with feces or external substances Cap specimen container securely Label container with identification information Submit specimen promptly to laboratory
- Additional Preparation Notes: Arrive on time for scheduled appointment Bring valid identification Inform staff of any medical conditions or concerns Inform staff if wearing colostomy or other urinary device Empty bladder completely for specimen collection For monitored collections, follow facility chain-of-custody procedures

How our test process works!